Scientists hunt for immune clues to beat rare blood cancers
NCT ID NCT07590986
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study looks at how the immune system responds to myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect blood and bone marrow samples from 150 adults with MPN and healthy volunteers to find immune cells that recognize cancer cells. The goal is to identify targets for future immune-based treatments. Participants will not receive direct medical benefit, but the findings could help develop new therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOPROLIFERATIVE NEOPLASM (MPN) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
de Duve Institute, UCLouvain
RECRUITINGBrussels, Woluwe, 1200, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.